Modulation of clinical expression of plaque-induced gingivitis: Interleukin-1 gene cluster polymorphisms

Journal of Periodontology

Volumn 76, Issue 1, 2005, Pages 49-56

  Scapoli, Chiara ^a   Tatakis, Dimitris N ^a,b   Mamolini, Elisabetta ^a   Trombelli, Leonardo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Dental plague adverse effects; Dental plaque adverse effects; Gingivitis etiology; Interleukin 1; Polymorphism, genetic

Indexed keywords

AGAROSE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GINGIVITIS; HUMAN; HUMAN EXPERIMENT; INTRON; MALE; ORAL BLEEDING; POLYMERASE CHAIN REACTION; RANDOMIZATION; RESTRICTION MAPPING; SCORING SYSTEM; TANDEM REPEAT; TOOTH PLAQUE;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DENTAL PLAQUE; FEMALE; GINGIVITIS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS; STATISTICS, NONPARAMETRIC;

EID: 15944372578     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.1.49     Document Type: Article

References (47)

1. Oliver RC, Brown LJ, Löe H. Periodontal diseases in the United States population. J Periodontol 1998;69:269-278.
2. Löe H, Anerud A, Boysen H, Morrison E. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 1986;13:431-445.
3. Lindhe J, Hamp S, Löe H. Experimental periodontitis in the beagle dog. J Periodontal Res 1973;8:1-10.
4. Tatakis DN, Trombelli L. Modulation of clinical expression of plaque-induced gingivitis. I. Background review and rationale. J Clin Periodontol 2004;31:229-238.
5. Wiedemann W, Lahrsow J, Naujoks R. The effect of periodontal resistance on experimental gingivitis (in German). Dtsch Zahnarztl Z 1979;34:6-9.
6. Watts TL. Variability of gingival bleeding in experimental gingivitis trials. Community Dent Oral Epidemiol 1978;6:253-255.
7. Abbas F, van der Velden U, Hart AA, Moorer WR, Vroom TM, Scholte G. Bleeding/plaque ratio and the development of gingival inflammation. J Clin Periodontol 1986;13:774-782.
8. van der Weijden GA, Timmerman MF, Danser MM, Nijboer A, Saxton CA, van der Velden U. Effect of preexperimental maintenance care duration on the development of gingivitis in a partial mouth experimental gingivitis model. J Periodontal Res 1994;29:168-173.
9. Trombelli L, Tatakis DN, Scapoli C, Bottega S, Orlandini E, Tosi M. Modulation of clinical expression of plaque-induced gingivitis. II. Identification of "high responder" and "low responder" subjects. J Clin Periodontol 2004; 31:239-252.
10. Reuland-Bosma W, van Dijk J, van der Weele L. Experimental gingivitis around deciduous teeth in children with Down's syndrome. J Clin Periodontol 1986;13:294-300.
11. Jepsen S, Eberhard J, Fricke D, Hedderich J, Siebert R, Acil Y. Interleukin-1 gene polymorphisms and experimental gingivitis. J Clin Periodontol 2003;30:102-106.
12. Hart TC, Kornman KS. Genetic factors in the pathogenesis of periodontitis. Periodontol 2000 1997;14:202-215.
13. Michalowicz BS, Diehl SR, Gunsolley JC, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 2000;71:1699-1707.
14. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
15. Galbraith GM, Hendley TM, Sanders JJ, Palesch Y, Pandey JP. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol 1999;26:705-709.
16. Kinane DF, Hodge P, Eskdale J, Ellis R, Gallagher G. Analysis of genetic polymorphisms at the interleukin-10 and tumour necrosis factor loci in early-onset periodontitis. J Periodontal Res 1999;34:379-386.
17. Ehmke B, Kress W, Karch H, Grimm T, Klaiber B, Flemmig TF. Interleukin-1 haplotype and periodontal disease progression following therapy. J Clin Periodontol 1999;26:810-813.
18. Diehl SR, Wang Y, Brooks CN, et al. Linkage disequilibrium of interieukin-1 genetic polymorphisms with early-onset periodontitis. J Periodontol 1999;70:418-430.
19. McDevitt MJ, Wang HY, Knobelman C, et al. Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol 2000;71:156-163.
20. Armitage GC, Wu Y, Wang HY, Sorrell J, di Giovine FS, Duff GW. Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. J Periodontol 2000;71:164-171.
21. Tatakis DN. Interleukin-1 and bone metabolism: A review. J Periodontol 1993;64:416-431.
22. Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol 1998;69:1419-1425.
23. Löe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965;36:177-187.
24. Trombelli L, Scapoli C, Orlandini E, Tosi M, Bottega S, Tatakis DN. Modulation of clinical expression of plaque-induced gingivitis. III. Response of "high responders" and "low responders" to therapy. J Clin Periodontol 2004;31: 253-259.
25. The World Medical Association Declaration. Ethical Principles for Medical Research Involving Human Subjects. Available at: www.wma.net/e/policy/b3.htm. Accessed April 13, 2004.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
27. Clay FE, Cork MJ, Tarlow JK, et al. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994;94:407-410.
28. Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1 - receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res 2000;15:402-414.
29. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-372.
30. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (lL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998;47: 195-198.
31. Mann CL, Davies MB, Stevenson VL, et al. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol 2002;129:197-204.
32. Goodson JM, Palys MD, Socransky SS. Gingival bleeding accentuated by plaque in healthy IL-1(+) genotype subjects. J Dent Res 2000;79(Spec. Issue):171 (Abstr. 221).
33. Laine ML, Farre MA, Gonzalez G, et al. Polymorphisms of the interleukin-1 gene family, oral microbial pathogens, and smoking in adult periodontitis. J Dent Res 2001;80: 1695-1699.
34. Duan H, Zhang J, Zhang Y. The association between IL-1 gene polymorphisms and susceptibility to severe periodontitis (in Chinese). Hua Xi Kou Qiang Yi Xue Za Zhi 2002;20:48-51.
35. Tai H, Endo M, Shimada Y, et al. Association of interleukin-1 receptor antagonist gene polymorphisms with early onset periodontitis in Japanese. J Clin Periodontol 2002;29:882-888.
36. Whyte M, Hubbard R, Meliconi R, et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000;162:755-758.
37. Kastrati A, Koch W, Berger PB, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000;36:2168-2173.
38. Ray KK, Camp NJ, Bennett CE, Francis SE, Crossman DC. Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes. Clin Sci (Lond) 2002;103:303-310.
39. Rocha V, Franco RF, Porcher R, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002;100:3908-3918.
40. Guzman S, Karima M, Wang HY, Van Dyke TE. Association between interleukin-1 genotype and periodontal disease in a diabetic population. J Periodontol 2003;74:1183-1190.
41. Soga Y, Nishimura F, Ohyama H, Maeda H, Takashiba S, Murayama Y. Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 2003;30:524-531.
42. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;47:571-574.
43. Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002;123:1793-1803.
44. Marculescu R, Mlekusch W, Exner M, et al. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty. Thromb Haemost 2003;90:491-500.
45. Rad R, Prinz C, Neu B, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003;188: 272-281.
46. Walker SJ, Van Dyke TE, Rich S, Kornman KS, di Giovine FS, Hart TC. Genetic polymorphisms of the IL-1A and IL-1B genes in African-American LJP patients and an African-American control population. J Periodontol 2000; 71:723-728.
47. Mozzato-Chamay N, Mahdi OS, Jallow O, Mabey DC, Bailey RL, Conway DJ. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis - endemic population. J Infect Dis 2000;182: 1545-1548.